0.31%QQQQ 43.45 
0.48%XLF 21.74 3.62%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK - Shares of BioMimetic Therapeutics are rising ahead of the medical products maker's full-year earnings report.
| BMTI | 10.3 |  -0.1 |
The company is developing products that combine drugs with medical devices to promote faster growth and healing of tissue. Wall Street thinks the Franklin, Tenn., company will report a loss of $1.30 per share on almost $8 million in sales.
In afternoon trading, BioMimetic Therapeutics Inc. stock gained 98 cents, or 8 percent, to $13.25.
Analyst Caroline Corner of Pacific Growth Equities thinks revenue will surge over the next few years, reaching $104 million in 2011.
She said BioMimetic products could treat a wide variety of ailments, which makes it unique. Corner thinks BioMimetic is an attractive buyout target for an orthopedics company.
The above adage is well known by precious-metals investors; in fact I used this quote in one of our monthly reports. I recall how many inquiries ...
The review was scathing. "She cannot sing very well," it said. "She is flat a go...
IN THE HEADLINES McCain caps GOP convention vowing 'change is coming' to Washing...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
